Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
The study’s promoter results span HEK293 and Jurkat cell-line profiling, selected-promoter testing in primary human CD8-positive T cells, in-vitro NR4A2-subset characterization, and tumor-infiltrating engineered T cells in a melanoma xenograft model; these are experimental-system findings rather than clinical human evidence.	OBSERVATIONAL	Supported	0.8581	1 of 4	90